107 related articles for article (PubMed ID: 19098386)
1. Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1.
Nagai T; Nabeshima T; Yamada K
J Pharmacol Sci; 2008 Dec; 108(4):408-14. PubMed ID: 19098386
[TBL] [Abstract][Full Text] [Related]
2. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1.
Nagai T; Ito M; Nakamichi N; Mizoguchi H; Kamei H; Fukakusa A; Nabeshima T; Takuma K; Yamada K
J Neurosci; 2006 Nov; 26(47):12374-83. PubMed ID: 17122062
[TBL] [Abstract][Full Text] [Related]
3. [Role of tissue plasminogen activator in the rewarding effect of nicotine].
Nagai T; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640
[TBL] [Abstract][Full Text] [Related]
4. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
Nagai T; Takuma K; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
[TBL] [Abstract][Full Text] [Related]
6. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
[TBL] [Abstract][Full Text] [Related]
7. [Role of tissue plasminogen activator in the rewarding effect of morphine].
Nagai T; Nabeshima T; Takuma K; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):23-30. PubMed ID: 16619846
[TBL] [Abstract][Full Text] [Related]
8. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
9. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509
[TBL] [Abstract][Full Text] [Related]
10. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
11. Involvement of tissue plasminogen activator "tPA" in ethanol-induced locomotor sensitization and conditioned-place preference.
Bahi A; Dreyer JL
Behav Brain Res; 2012 Jan; 226(1):250-8. PubMed ID: 21945298
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.
Zalfa C; Azmoon P; Mantuano E; Gonias SL
J Leukoc Biol; 2019 Apr; 105(4):729-740. PubMed ID: 30690783
[TBL] [Abstract][Full Text] [Related]
13. Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
Ito M; Nagai T; Mizoguchi H; Sato K; Hayase M; Otsuka N; Fukakusa A; Kumagai N; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Dec; 103(6):2589-96. PubMed ID: 17944865
[TBL] [Abstract][Full Text] [Related]
14. Drug dependence, synaptic plasticity, and tissue plasminogen activator.
Yamada K; Nagai T; Nabeshima T
J Pharmacol Sci; 2005 Feb; 97(2):157-61. PubMed ID: 15684570
[TBL] [Abstract][Full Text] [Related]
15. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based medication development for the treatment of nicotine dependence.
Xi ZX; Spiller K; Gardner EL
Acta Pharmacol Sin; 2009 Jun; 30(6):723-39. PubMed ID: 19434058
[TBL] [Abstract][Full Text] [Related]
18. Characteristic response of astrocytes to plasminogen/plasmin to upregulate transforming growth factor beta 3 (TGFbeta3) production/secretion through proteinase-activated receptor-1 (PAR-1) and the downstream phosphatidylinositol 3-kinase (PI3K)-Akt/PKB signaling cascade.
Maeda S; Nakajima K; Tohyama Y; Kohsaka S
Brain Res; 2009 Dec; 1305():1-13. PubMed ID: 19765562
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator-plasmin-BDNF modulate glutamate-induced phase-shifts of the mouse suprachiasmatic circadian clock in vitro.
Mou X; Peterson CB; Prosser RA
Eur J Neurosci; 2009 Oct; 30(8):1451-60. PubMed ID: 19811533
[TBL] [Abstract][Full Text] [Related]
20. The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate.
Wu YP; Siao CJ; Lu W; Sung TC; Frohman MA; Milev P; Bugge TH; Degen JL; Levine JM; Margolis RU; Tsirka SE
J Cell Biol; 2000 Mar; 148(6):1295-304. PubMed ID: 10725341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
